Table 5.
Five year relative survival of patients diagnosed with CML in Germany and the US for (a) men and (b) women, 2002–06
| |
Germany |
US |
||||||
|---|---|---|---|---|---|---|---|---|
| Age | N | RS | SE | N | RS | SE | Diff | P (Model) |
| a. Men | ||||||||
| 15-39 |
207 |
78.4 |
4.1 |
528 |
80.6 |
2.6 |
−2.2 |
0.5275 |
| 40-49 |
184 |
76.5 |
4.5 |
383 |
80.5 |
3.1 |
−4 |
0.3275 |
| 50-59 |
234 |
65.1 |
5.1 |
401 |
73.9 |
3.5 |
−8.8 |
0.0575 |
| 60-64 |
207 |
61.5 |
5.6 |
191 |
68.8 |
5.5 |
−7.3 |
0.3367 |
| 65-69 |
242 |
50.3 |
5.5 |
204 |
48.9 |
5.7 |
+1.4 |
0.6480 |
| Overall |
1074 |
65.5 |
2.3 |
1707 |
69.7a |
2.0 |
−4.2 |
0.0273 |
| b. Women | ||||||||
| 15-39 |
117 |
91.2 |
4.0 |
290 |
84.4 |
3.1 |
+6.8 |
0.2632 |
| 40-49 |
144 |
80.1 |
5.0 |
297 |
85.8 |
3.1 |
−5.7 |
0.3460 |
| 50-59 |
189 |
69.6 |
4.8 |
296 |
84.0 |
3.6 |
−14.6 |
0.0050 |
| 60-64 |
154 |
69.1 |
5.3 |
149 |
71.7 |
6.1 |
−2.6 |
0.4252 |
| 65-69 |
170 |
59.2 |
5.5 |
171 |
61.4 |
6.1 |
−2.2 |
0.6316 |
| Overall | 774 | 72.8 | 2.3 | 1203 | 77.0a | 2.1 | −4.2 | 0.0453 |
a = age adjusted using the percentage of cases in each age group in Germany.
N = Number of cases.
RS = 5-year relative survival.
SE = Standard Error.
Diff = Difference between survival in Germany and the US.